- Report
- April 2022
- 326 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- September 2021
- 262 Pages
Global
From €3275EUR$3,750USD£2,845GBP
- Report
- March 2024
- 197 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- March 2024
- 183 Pages
Global
From €3096EUR$3,545USD£2,690GBP
€3440EUR$3,939USD£2,988GBP
- Report
- August 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- April 2024
- 279 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- January 2024
- 244 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- February 2023
- 175 Pages
Global
From €4367EUR$5,000USD£3,793GBP
- Report
- January 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- January 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- January 2024
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- November 2023
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- October 2023
- 150 Pages
Global
From €3362EUR$3,850USD£2,921GBP
€4236EUR$4,850USD£3,680GBP
- Report
- January 2024
- 148 Pages
Global
From €2969EUR$3,400USD£2,579GBP
€3712EUR$4,250USD£3,224GBP
- Report
- June 2024
- 176 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- May 2024
- 170 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- April 2024
- 176 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- June 2023
- 118 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- August 2022
- 115 Pages
Global
From €3930EUR$4,500USD£3,414GBP
- Report
- August 2022
- 119 Pages
Global
From €3930EUR$4,500USD£3,414GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more